- Home
- WIA vs AMRN Comparison
WIA vs AMRN Comparison
Compare WIA & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- AMRN
- Stock Information
- Founded
- WIA 2003
- AMRN 1989
- Country
- WIA United States
- AMRN Ireland
- Employees
- WIA N/A
- AMRN N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WIA Finance
- AMRN Health Care
- Exchange
- WIA Nasdaq
- AMRN Nasdaq
- Market Cap
- WIA 192.9M
- AMRN 216.0M
- IPO Year
- WIA N/A
- AMRN 1993
- Fundamental
- Price
- WIA $8.37
- AMRN $16.90
- Analyst Decision
- WIA
- AMRN Strong Sell
- Analyst Count
- WIA 0
- AMRN 1
- Target Price
- WIA N/A
- AMRN $12.00
- AVG Volume (30 Days)
- WIA 39.2K
- AMRN 171.7K
- Earning Date
- WIA 01-01-0001
- AMRN 07-30-2025
- Dividend Yield
- WIA 12.29%
- AMRN N/A
- EPS Growth
- WIA N/A
- AMRN N/A
- EPS
- WIA N/A
- AMRN N/A
- Revenue
- WIA N/A
- AMRN $214,112,000.00
- Revenue This Year
- WIA N/A
- AMRN N/A
- Revenue Next Year
- WIA N/A
- AMRN N/A
- P/E Ratio
- WIA N/A
- AMRN N/A
- Revenue Growth
- WIA N/A
- AMRN N/A
- 52 Week Low
- WIA $7.56
- AMRN $7.08
- 52 Week High
- WIA $8.91
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- WIA 60.11
- AMRN 71.53
- Support Level
- WIA $8.25
- AMRN $16.12
- Resistance Level
- WIA $8.44
- AMRN $17.49
- Average True Range (ATR)
- WIA 0.06
- AMRN 0.96
- MACD
- WIA -0.00
- AMRN 0.05
- Stochastic Oscillator
- WIA 57.14
- AMRN 90.37
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.